A single arm, open-label, phase II study to assess the efficacy of lucitanib in patients with FGFR1-amplified squamous NSCLC (sqNSCLC).
David R. Spigel
Consultant or Advisory Role - Clovis (U)
Roberta Cereda
Employment or Leadership Position - EOS S.p.A.
Jason B. Litten
Employment or Leadership Position - Clovis
Stock Ownership - Clovis
Andrew R. Allen
Employment or Leadership Position - Clovis
Stock Ownership - Clovis
Giuseppe Giaccone
Consultant or Advisory Role - Clovis (U)
Mark A. Socinski
No relevant relationships to disclose
D. Ross Camidge
Consultant or Advisory Role - Clovis
Benjamin Besse
No relevant relationships to disclose